logo
Plus   Neg
Share
Email

Triple-S Management Q1 Profit Rises; Backs FY13 Pro Forma EPS View - Quick Facts

Triple-S Management Corp. (GTS), reported that its first-quarter net income attributable to the company was $17.24 million or $0.61 per share, up from $7.51 million or $0.26 per share in the same quarter last year.

Pro Forma net income for the quarter was $15.6 million, or $0.55 per share, up from $6.1 million or $0.21 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.35 per share for the quarter. Analysts' estimates typically exclude special items.

Total operating revenues for the quarter rose to $589.62 million from $587.07 million in the prior year quarter. Two analysts had consensus revenue estimate of $591.83 million for the quarter.

Looking ahead to the fiscal year 2013, the company still expects Pro forma earnings in the range of $1.90 to $2.00 per share. Consolidated operating revenues are expected to be in the range of $2.35 billion - $2.45 billion. Analysts expect the company to report earnings of $1.99 per share on revenues of $2.39 billion for fiscal 2013.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT